Nextgenjane, Inc.
Publicly observedOakland, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Oakland | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Nextgenjane, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | EWN3LW7S8NP5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Apr 2025Publicly observed
NIH SBIR/STTR award: Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients
USD 714,095.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant15 Apr 2025Publicly observed
NIH SBIR/STTR award: Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients
USD 759,944.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.